Cargando…

Development of Two Diagnostic Prediction Models for Leptomeningeal Metastasis in Patients With Solid Tumors

OBJECTIVES: For accurate diagnosis of leptomeningeal metastasis (LM) and to avoid unnecessary examinations or lumber puncture (LP), we develop two diagnostic prediction models for patients with solid tumors. STUDY DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective cohort study launched at th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Tianqi, Chen, Fengxi, Li, Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168081/
https://www.ncbi.nlm.nih.gov/pubmed/35677335
http://dx.doi.org/10.3389/fneur.2022.899153
_version_ 1784720921002508288
author Gao, Tianqi
Chen, Fengxi
Li, Man
author_facet Gao, Tianqi
Chen, Fengxi
Li, Man
author_sort Gao, Tianqi
collection PubMed
description OBJECTIVES: For accurate diagnosis of leptomeningeal metastasis (LM) and to avoid unnecessary examinations or lumber puncture (LP), we develop two diagnostic prediction models for patients with solid tumors. STUDY DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective cohort study launched at the Second Affiliated Hospital of Dalian Medical University. In total, 206 patients who had been admitted between January 2005 and December 2021 with a solid tumor and clinical suspicion of LM were enrolled to develop model A. In total, 152 patients of them who underwent LPs for cytology and biochemistry were enrolled to develop model B. MODEL DEVELOPMENT: Diagnostic factors included skull metastasis, active brain metastasis, progressed extracranial disease, number of extracranial organs involved, number of symptoms, cerebrospinal fluid (CSF) protein, and CSF glucose. The outcome predictor was defined as the clinical diagnosis of LM. Logistic least absolute shrinkage and selection operator (LASSO) regression was used to identify relevant variables and fit the prediction model. A calibration curve and the concordance index (c-index) were used to evaluate calibration and discrimination ability. The n-fold cross-validation method was used to internally validate the models. The decision curve analysis (DCA) and the interventions avoided analysis (IAA) were used to evaluate the clinical application. RESULTS: The area under the curve (AUC) values of models A and B were 0.812 (95% CI: 0.751–0.874) and 0.901 (95% CI: 0.852–0.949). Respectively, compared to the first magnetic resonance imaging (MRI) and first LP, models A and B showed a higher AUC (model A vs. first MRI: 0.812 vs. 0.743, p = 0.087; model B vs. first LP: 0.901 vs. 0.800, p = 0.010). The validated c-indexes were 0.810 (95% CI: 0.670–0.952) and 0.899 (95% CI: 0.823–0.977). The calibration curves show a good calibrated ability. The evaluation of clinical application revealed a net clinical benefit and a reduction of unnecessary interventions using the models. CONCLUSIONS: The models can help improve diagnostic accuracy when used alone or in combination with conventional work-up. They also exhibit a net clinical benefit in medical decisions and in avoiding unnecessary interventions for patients with LM. Studies focused on external validation of our models are necessary in the future.
format Online
Article
Text
id pubmed-9168081
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91680812022-06-07 Development of Two Diagnostic Prediction Models for Leptomeningeal Metastasis in Patients With Solid Tumors Gao, Tianqi Chen, Fengxi Li, Man Front Neurol Neurology OBJECTIVES: For accurate diagnosis of leptomeningeal metastasis (LM) and to avoid unnecessary examinations or lumber puncture (LP), we develop two diagnostic prediction models for patients with solid tumors. STUDY DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective cohort study launched at the Second Affiliated Hospital of Dalian Medical University. In total, 206 patients who had been admitted between January 2005 and December 2021 with a solid tumor and clinical suspicion of LM were enrolled to develop model A. In total, 152 patients of them who underwent LPs for cytology and biochemistry were enrolled to develop model B. MODEL DEVELOPMENT: Diagnostic factors included skull metastasis, active brain metastasis, progressed extracranial disease, number of extracranial organs involved, number of symptoms, cerebrospinal fluid (CSF) protein, and CSF glucose. The outcome predictor was defined as the clinical diagnosis of LM. Logistic least absolute shrinkage and selection operator (LASSO) regression was used to identify relevant variables and fit the prediction model. A calibration curve and the concordance index (c-index) were used to evaluate calibration and discrimination ability. The n-fold cross-validation method was used to internally validate the models. The decision curve analysis (DCA) and the interventions avoided analysis (IAA) were used to evaluate the clinical application. RESULTS: The area under the curve (AUC) values of models A and B were 0.812 (95% CI: 0.751–0.874) and 0.901 (95% CI: 0.852–0.949). Respectively, compared to the first magnetic resonance imaging (MRI) and first LP, models A and B showed a higher AUC (model A vs. first MRI: 0.812 vs. 0.743, p = 0.087; model B vs. first LP: 0.901 vs. 0.800, p = 0.010). The validated c-indexes were 0.810 (95% CI: 0.670–0.952) and 0.899 (95% CI: 0.823–0.977). The calibration curves show a good calibrated ability. The evaluation of clinical application revealed a net clinical benefit and a reduction of unnecessary interventions using the models. CONCLUSIONS: The models can help improve diagnostic accuracy when used alone or in combination with conventional work-up. They also exhibit a net clinical benefit in medical decisions and in avoiding unnecessary interventions for patients with LM. Studies focused on external validation of our models are necessary in the future. Frontiers Media S.A. 2022-05-23 /pmc/articles/PMC9168081/ /pubmed/35677335 http://dx.doi.org/10.3389/fneur.2022.899153 Text en Copyright © 2022 Gao, Chen and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Gao, Tianqi
Chen, Fengxi
Li, Man
Development of Two Diagnostic Prediction Models for Leptomeningeal Metastasis in Patients With Solid Tumors
title Development of Two Diagnostic Prediction Models for Leptomeningeal Metastasis in Patients With Solid Tumors
title_full Development of Two Diagnostic Prediction Models for Leptomeningeal Metastasis in Patients With Solid Tumors
title_fullStr Development of Two Diagnostic Prediction Models for Leptomeningeal Metastasis in Patients With Solid Tumors
title_full_unstemmed Development of Two Diagnostic Prediction Models for Leptomeningeal Metastasis in Patients With Solid Tumors
title_short Development of Two Diagnostic Prediction Models for Leptomeningeal Metastasis in Patients With Solid Tumors
title_sort development of two diagnostic prediction models for leptomeningeal metastasis in patients with solid tumors
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168081/
https://www.ncbi.nlm.nih.gov/pubmed/35677335
http://dx.doi.org/10.3389/fneur.2022.899153
work_keys_str_mv AT gaotianqi developmentoftwodiagnosticpredictionmodelsforleptomeningealmetastasisinpatientswithsolidtumors
AT chenfengxi developmentoftwodiagnosticpredictionmodelsforleptomeningealmetastasisinpatientswithsolidtumors
AT liman developmentoftwodiagnosticpredictionmodelsforleptomeningealmetastasisinpatientswithsolidtumors